Medication Adherence Patterns, Equity Monitoring, and Glycemic Control across Community Diabetes Clinics
Keywords:
Glycemic Control, Medication Adherence, Health Equity, Community Clinics, Equity MonitoringAbstract
The management of type 2 diabetes mellitus in community health settings represents a complex challenge that is profoundly influenced by patient behaviors and structural health inequities. This paper investigates the critical intersection of medication adherence patterns and equity monitoring to explain variations in glycemic control among diverse patient populations. By deploying a comprehensive analytical framework within community diabetes clinics, this research identifies distinct longitudinal trajectories of medication adherence and examines how these trajectories are shaped by social determinants of health. The study utilizes electronic health records, pharmacy dispensing data, and specialized equity indices to evaluate the disproportionate burden of suboptimal glycemic outcomes on marginalized communities. The findings indicate that erratic and declining adherence patterns are strongly correlated with elevated hemoglobin A1c levels and are disproportionately prevalent among socioeconomically disadvantaged groups. Furthermore, the integration of routine equity monitoring into clinical workflows provides actionable insights that can drive targeted, culturally responsive interventions. Ultimately, this research underscores the necessity of moving beyond traditional, individualized models of compliance to adopt systemic, equity-informed strategies that address the root causes of treatment failure in chronic disease management.References
1. Gao, J. P-values—A chronic conundrum. BMC Med. Res. Methodol. 2020, 20, 167.
2. Deborah, G. Mayo Statistical Inference as Severe Testing: How to Get Beyond the Statistics Wars; Cambridge University Press: Cambridge, UK, 2018; 500p.
3. Dequin, P.F.; Meziani, F.; Quenot, J.P.; Kamel, T.; Ricard, J.D.; Badie, J.; Reignier, J.; Heming, N.; Plantefève, G.; Souweine, B.; et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N. Engl. J. Med. 2023, 388, 1931–1941.
4. Ernstmeyer, K.; Christman, E. Nursing Pharmacology, 2nd ed.; Chippewa Valley Technical College: Eau Claire, WI, USA, 2023.
5. Almazroo, O.A.; Miah, M.K.; Venkataramanan, R. Drug Metabolism in the Liver. Clin. Liver Dis. 2017, 21, 1–20.
6. Aden, H.; Mohamud, A.A.; Hassan, A.I.; Fiidow, O.A.; Bashir, A.M. Association Between Breast Microbiota and Capsular Contracture: A Systematic Review. Aesthetic Surg. J. Open Forum 2025, 7, ojaf128.
7. Haas, E.; Christodoulou, N.; Secanho, M.; Kokosis, G.; Malgor, R.D.; Winocour, J.; Yu, J.W.; Mathes, D.W.; Kaoutzanis, C. Capsular Contracture After Breast Augmentation: A Systematic Review and Meta-Analysis. Aesthetic Surg. J. Open Forum 2025, 7, ojaf003.
8. Zhao, M.; Ma, J.; Li, M.; Zhang, Y.; Jiang, B.; Zhao, X.; Huai, C.; Shen, L.; Zhang, N.; He, L.; et al. Cytochrome P450 Enzymes and Drug Metabolism in Humans. Int. J. Mol. Sci. 2021, 22, 12808.
9. Keller, G.A.; Gago, M.L.F.; Diez, R.A.; Di Girolamo, G. In vivo Phenotyping Methods: Cytochrome P450 Probes with Emphasis on the Cocktail Approach. Curr. Pharm. Des. 2017, 23, 2035–2049.
10. Longacre, J.J. Correction of the hypoplastic breast with special reference to reconstruction of the “nipple type breast” with local dermo-fat pedicle flaps. Plast. Reconstr. Surg. 1954, 14, 431–441.
11. Lytsy, P.; Hartman, M.; Pingel, R. Misinterpretations of P-values and statistical tests persists among researchers and professionals working with statistics and epidemiology. Upsala J. Med. Sci. 2022, 127, 10-48101.
12. Ruberg, S.J.; Beckers, F.; Hemmings, R.; Honig, P.; Irony, T.; LaVange, L.; Lieberman, G.; Mayne, J.; Moscicki, R. Application of Bayesian approaches in drug development: Starting a virtuous cycle. Nat. Rev. Drug Discov. 2023, 22, 235–250. [ Central]
13. Anderson, J.M.; Rodriguez, A.; Chang, D.T. Foreign Body Reaction to Biomaterials. Semin. Immunol. 2008, 20, 86–100.
14. Raj, S.D.; Karimova, E.J.; Fishman, M.D.C.; Fein-Zachary, V.; Phillips, J.; Dialani, V.; Slanetz, P.J. Imaging of Breast Implant-Associated Complications and Pathologic Conditions: Breast Imaging. Radiogr. Rev. Publ. Radiol. Soc. N. Am. Inc. 2017, 37, 1603–1604.
15. Mayo, D.G.; Spanos, A. Severe Testing as a Basic Concept in a Neyman–Pearson Philosophy of Induction. Br. J. Philos. Sci. 2006, 57, 323–357.
16. Zhai, P.; Wu, Y.; Yang, D.; Ma, W.; Zhai, Y.; Xie, H. A Systematic Review and Meta-Analysis of Capsular Contracture Rate after Breast Augmentation with Textured and Smooth Breast Prostheses. Gland Surg. 2022, 11, 166–174.
17. Trabilsy, M.; Haider, S.A.; Borna, S.; Gomez-Cabello, C.A.; Genovese, A.; Prabha, S.; Forte, A.J.; Rinker, B.D.; Ho, O.A.; Elegbede, A.I. Exploring Breast Implant Illness and Its Comorbid Conditions: A Systematic Review & Meta-Analysis. J. Plast. Reconstr. Aesthet. Surg. 2025, 105, 41–54.
18. Amrhein, V.; Greenland, S. Remove, rather than redefine, statistical significance. Nat. Hum. Behav. 2018, 2, 4.
19. Aczel, B.; Hoekstra, R.; Gelman, A.; Wagenmakers, E.-J.; Klugkist, I.G.; Rouder, J.N.; Vandekerckhove, J.; Lee, M.D.; Morey, R.D.; Vanpaemel, W.; et al. Discussion points for Bayesian inference. Nat. Hum. Behav. 2020, 4, 561–563.
20. Junior, I.; Graf, R.; Ascenço, A.; Itikawa, W.; Balbinot, P.; Mendonça Munhoz, A.; Lopes, M.; Nasser, I.; Urban, L.; Freitas, R. Is There a Breast Augmentation Outcome Difference Between Subfascial and Subglandular Implant Placement? A Prospective Randomized Double-Blinded Study. Aesthetic Plast. Surg. 2019, 43, 1429–1436.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Authors
This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0), unless otherwise stated.
